RESEARCH PARTICIPATION OPPORTUNITIES

Dr. Jacqueline Harris, MD, Kennedy Krieger Institute/Johns Hopkins Medical Institution, specializes in patients with epigenetic disorders with neurologic and/or cognitive manifestations in Kabuki Syndrome.  Dr. Harris is currently conducting several research studies and is seeking participants.  Please see the individual study details below.

kki-black.png
logoJohnsHopkinsMedicineHorizontal.jpeg

Virtual Research Study: Understanding Sleep, Behavior, and Quality of Life in Kabuki Syndrome

A Clinical Study of the Brain and Cognition in Kabuki Syndrome

A Pilot Trial of a Dietary Therapy for Kabuki Syndrome

LATEST NEWS & INFORMATION

Oryzon announces $1 million grant from Kabuki syndrome philanthropists to support a precision medicine Phase I/II trial with vafidemstat

  • HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseases

  • Multicentric study to assess the efficacy of vafidemstat in Kabuki Syndrome patients

  • Expected to start in early 2022

  • In collaboration with the Kennedy-Krieger Institute

Oryzon logo.png